DE602004024584D1 - Inhibitoren der nicht-nukleotidischen reversen transkriptase - Google Patents

Inhibitoren der nicht-nukleotidischen reversen transkriptase

Info

Publication number
DE602004024584D1
DE602004024584D1 DE602004024584T DE602004024584T DE602004024584D1 DE 602004024584 D1 DE602004024584 D1 DE 602004024584D1 DE 602004024584 T DE602004024584 T DE 602004024584T DE 602004024584 T DE602004024584 T DE 602004024584T DE 602004024584 D1 DE602004024584 D1 DE 602004024584D1
Authority
DE
Germany
Prior art keywords
alkyl
orx
nrxrx
nucleotidic
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004024584T
Other languages
German (de)
English (en)
Inventor
Christian Sund
Nathalie Roue
Stefan Lindstroem
Dmitry Antonov
Christer Sahlberg
Katarina Jansson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medivir AB
Original Assignee
Medivir AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0400021A external-priority patent/SE0400021D0/xx
Priority claimed from SE0400585A external-priority patent/SE0400585D0/xx
Application filed by Medivir AB filed Critical Medivir AB
Publication of DE602004024584D1 publication Critical patent/DE602004024584D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE602004024584T 2004-01-08 2004-12-30 Inhibitoren der nicht-nukleotidischen reversen transkriptase Expired - Lifetime DE602004024584D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0400021A SE0400021D0 (sv) 2004-01-08 2004-01-08 Non-nucleoside reverse transcriptase inhibitors
SE0400585A SE0400585D0 (sv) 2004-03-09 2004-03-09 NNRTI Antivirals
PCT/SE2004/002034 WO2005066131A1 (en) 2004-01-08 2004-12-30 Non-nucleotide reverse transcriptase inhibitors

Publications (1)

Publication Number Publication Date
DE602004024584D1 true DE602004024584D1 (de) 2010-01-21

Family

ID=34752289

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004024584T Expired - Lifetime DE602004024584D1 (de) 2004-01-08 2004-12-30 Inhibitoren der nicht-nukleotidischen reversen transkriptase

Country Status (15)

Country Link
US (1) US7915295B2 (cg-RX-API-DMAC7.html)
EP (1) EP1701942B1 (cg-RX-API-DMAC7.html)
JP (1) JP4762917B2 (cg-RX-API-DMAC7.html)
AT (1) ATE451357T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004312284B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0418306B8 (cg-RX-API-DMAC7.html)
CA (1) CA2550187C (cg-RX-API-DMAC7.html)
DE (1) DE602004024584D1 (cg-RX-API-DMAC7.html)
DK (1) DK1701942T3 (cg-RX-API-DMAC7.html)
EA (1) EA009700B1 (cg-RX-API-DMAC7.html)
ES (1) ES2337794T3 (cg-RX-API-DMAC7.html)
IL (1) IL176740A (cg-RX-API-DMAC7.html)
NZ (1) NZ548367A (cg-RX-API-DMAC7.html)
SG (1) SG149070A1 (cg-RX-API-DMAC7.html)
WO (1) WO2005066131A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050033663A (ko) * 2002-09-05 2005-04-12 메디비르 아베 비-뉴클레오시드 역전사효소 억제제
US7388008B2 (en) 2004-08-02 2008-06-17 Ambrilia Biopharma Inc. Lysine based compounds
US20060287316A1 (en) * 2005-04-27 2006-12-21 Ambrilia Biopharma Inc. Method for improving pharmacokinetics of protease inhibitors and protease inhibitor precursors
WO2007062526A1 (en) 2005-11-30 2007-06-07 Ambrilia Biopharma Inc. Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation
GB0608876D0 (en) * 2006-05-05 2006-06-14 Medivir Ab Combination therapy
AU2007254325B2 (en) * 2006-05-15 2012-05-10 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
ES2628730T3 (es) 2006-09-21 2017-08-03 Taimed Biologics, Inc. Inhibidores de proteasa
EP3250552B1 (en) * 2015-01-30 2019-03-27 Genentech, Inc. Therapeutic compounds and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9906933A (pt) * 1998-01-16 2001-11-27 Medivir Ab Antiviróticos
WO1999051613A1 (en) * 1998-04-03 1999-10-14 Medivir Ab Prodrugs of phosphorous-containing pharmaceuticals
SE0100733D0 (sv) 2001-03-05 2001-03-05 Medivir Ab Non-nucleoside reverse transcriptase inhibitors
SE0102867D0 (sv) * 2001-08-28 2001-08-28 Medivir Ab Non-nucleoside reverse transcriptase inhibitors
KR20050033663A (ko) * 2002-09-05 2005-04-12 메디비르 아베 비-뉴클레오시드 역전사효소 억제제

Also Published As

Publication number Publication date
AU2004312284A1 (en) 2005-07-21
US7915295B2 (en) 2011-03-29
BRPI0418306B1 (pt) 2018-09-18
JP2007519640A (ja) 2007-07-19
SG149070A1 (en) 2009-01-29
DK1701942T3 (da) 2010-04-06
BRPI0418306A (pt) 2007-05-02
IL176740A0 (en) 2006-10-31
CA2550187A1 (en) 2005-07-21
CA2550187C (en) 2012-08-07
WO2005066131A1 (en) 2005-07-21
EA200601289A1 (ru) 2006-12-29
IL176740A (en) 2011-09-27
EP1701942A1 (en) 2006-09-20
ATE451357T1 (de) 2009-12-15
US20080070951A1 (en) 2008-03-20
ES2337794T3 (es) 2010-04-29
AU2004312284B2 (en) 2010-08-05
BRPI0418306B8 (pt) 2021-05-25
AU2004312284A2 (en) 2005-07-21
HK1101400A1 (en) 2007-10-18
EP1701942B1 (en) 2009-12-09
NZ548367A (en) 2010-06-25
EA009700B1 (ru) 2008-02-28
JP4762917B2 (ja) 2011-08-31

Similar Documents

Publication Publication Date Title
EA200602060A1 (ru) Производные пирролидин-2-она и пиперидин-2-она, используемые в качестве ингибиторов 11-бета-гидроксистероид-дегидрогеназы
PH12012501773A1 (en) Arylethynyl derivatives
TW200608972A (en) Aryl-pyridine derivatives
NZ596615A (en) Substituted isoquinoline derivative
CY1111310T1 (el) Ενωσεις για την αγωγη μεταβολικων διαταραχων
JP2013531029A5 (cg-RX-API-DMAC7.html)
EA201591000A1 (ru) Пирролобензодиазепины
NO20080738L (no) Fremgangsmater for neurobeskyttelse
MX2014004144A (es) Derivados de etinilo como moduladores alostericos del receptor de glutamato metabotropico del subtipo 5 (mglur5).
WO2008108386A1 (ja) 医薬組成物
AR039698A1 (es) Agonistas de los receptores cannabinoides
DE602006009080D1 (de) 1-essigsäureindolderivate mit pgd2-antagonistischer wirkung
JP2010527915A5 (cg-RX-API-DMAC7.html)
DE69003200D1 (de) Arylsubstituierte Aminderivate verwendbar in der Krebstherapie.
BRPI0518068A (pt) composto ou um éster ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, inibidor seletivo de aurora a, agente anti-tumor, e, preparação combinada
EA200970793A1 (ru) Модуляторы рецепторов, активируемых пролифераторами пероксисом
ATE451357T1 (de) Inhibitoren der nicht-nukleotidischen reversen transkriptase
EA201101298A1 (ru) Аддитивные соли трометамина с производными азабифениламинобензойной кислоты в качестве ингибиторов dhodh
RU2010115337A (ru) Трициклические гетероциклические производные
WO2009007536A3 (fr) Dérivés de 7 -alkynyl-1,8-naphthyridones, leur préparation et leur application en thérapeutique
WO2008078445A1 (ja) 重合性化合物及び重合性組成物
CO5690608A2 (es) 4-anilino-3-quinolincarbonitrilos para el tratamiento de leucemia mielogena cronica
CO5170535A1 (es) Derivados de n-[2-(4-aminofenil)etil]2,3-dihidro-1,4- benzodioxin-2-metanamina, su preparacion y su aplciacion en terapeutica
BRPI0607407A2 (pt) derivados de mentano carboxamida tendo propriedades de refrescáncia
SE0400021D0 (sv) Non-nucleoside reverse transcriptase inhibitors

Legal Events

Date Code Title Description
8364 No opposition during term of opposition